MIS2017 Panel Preview - State of Healthcare Innovation: A Pharma Perspective
When it comes to drug pricing, healthcare is still in gridlock. While hospitals are working to streamline care and remove costs, the drug industry is putting higher and higher prices on their medications. Pharma companies contend that they are simply accounting for the tremendous resources invested in R&D. Providers, of course, want to prescribe the best treatment for their patients, regardless of price. Yet, insurance companies and formulary companies are hesitant, and often unable, to pay the exorbitant prices.